Indication
Male pattern baldness, Alopecia androgenetica
Administration
Hair and scalp should be thoroughly dry prior to topical application of Minoxidil. A dose of 1 ml Minoxidil cutaneous solution should be applied to the total affected areas of the scalp twice daily. The total dosage should not exceed 2 ml. If fingertips are used to facilitate drug application, hands should be washed afterwards.
Adult Dose
Androgenetic Alopecia Male: Apply 1 mL of 2% or 5% solution to affected areas of scalp BID; no more than 2 ml in 24 hours Female: Apply 1 mL of 2% solution to affected areas of scalp BID It should be used twice daily for four months or more before evidence of hair growth can be expected.
Child Dose
<18 years old: Safety & efficacy not established
Interaction
Because of the increased absorption of Minoxidil, it should not be used with other topical treatments that modify the stratum corneum barrier, such as tretinoin or dithranol. Although there is no clinical evidence, absorbed Minoxidil has the potential to potentiate orthostatic hypotension produced by peripheral vasodilators.
Contraindications
Patients suffering from heart problems
Children under the age of eighteen
Patients who have been utilizing occlusive dressings or other medications on their scalp.
Patients who have a red, inflamed infection, as well as an irritated or painful scalp (including psoriasis & sunburn)
Pregnancy & Lactation
Because of the increased absorption of Minoxidil, it should not be used with other topical treatments that modify the stratum corneum barrier, such as tretinoin or dithranol. Although there is no clinical evidence, absorbed Minoxidil has the potential to potentiate orthostatic hypotension produced by peripheral vasodilators.
Precautions & Warnings
Minoxidil topical solution is more likely to cause scalp irritation. If scalp irritation continues or worsen, use of Minoxidil topical solution should be stopped.
Side Effect
1-10% Allergic contact dermatitis (7.4%),Tendonitis (2.6%) Frequency Not Defined Irritation,Burning,Erythema at site of application,May see systemic effects (hypotension)
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.